Blog

https://biobuzz.io/brian-stamper-appointed-vice-president-cell-therapy-operations-at-immunomic-therapeutics/

Immunomic Therapeutics highlighted in Washington Business Journal as a life sciences leader in Maryland’s Montgomery County: The Immunology Capital Next to the Nation’s Capital. Click here to read more: http://ow.ly/NQrc50IVzkT

Claire Rosean, Senior Scientist discusses ITI-3000, First-In-Human Trial for Merkel Cell Carcinoma and the preclinical data presented at AACR. Click below to watch the full interview: https://www.oncologytube.com/video/40935/claire-rosean-phd-immunomix-uw-aacr22-mcc-iti-3000-first-in-human-trial?channelName=AACR 

Messages from our CEO, Dr. Bill Hearl on Immunology, Glioblastoma, the UNITE platform, and Clinical Trials.

The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting & Pre-Conference Programs (SITC 2021) will take place on Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington,

World Vaccine Congress remains the industry’s definitive vaccine industry event for major vaccine players and their respective senior-level representatives More detailed information to come.

Immunomic Therapeutics, Inc. today presented late-breaking preclinical data which shows that its investigational nucleic acid platform, UNITE, may enhance antitumor immunity when used in connection with its investigational DNA vaccine,

ITI's Michael Connolly, Manager of Process Development, presents a poster titled, "Functional evaluation of isoforms present in pDNA vaccines" at Aldevron's corporate offices located in Fargo, North Dakota A detailed abstract

Our very own Dr. Heiland has been featured on BioBuzz.  Click below to read the full Q&A Interview, as Dr. Heiland discusses our technology platform name change to UNITE and

Please read the article authored by ITI titled, “The Use and Misuse of Cancer Life Expectancy Statistics” which explores how GBM patients adjust and deal with dire life expectancy statistics.

August is National Immunization Awareness Month, and it provides an excellent opportunity to celebrate how vaccines have greatly reduced disease, disability and death. In 1796, there was one documented successful

Senator McCain fought glioblastoma bravely. Our team, and scientists around the world, remain committed to researching treatment options.  Read Dr. Mitchell's article on the progress being made in the treatment